Autophagy induction sensitizes cancer cells to anti-cancer drugs

被引:3
|
作者
Luo, Mei [1 ]
Han, Leng [2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Texas A&M Univ, Inst Biosci & Technol, Ctr Epigenet & Dis Prevent, Houston, TX 77030 USA
[3] Texas A&M Univ, Coll Med, Dept Translat Med Sci, Houston, TX 77030 USA
关键词
Autophagy; drug sensitivity; gene signature; multi-omics; therapy;
D O I
10.1080/15548627.2022.2162703
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Resistance to anti-cancer therapy is a major challenge for cancer treatment. Many studies revealed that macroautophagy/autophagy inhibition can overcome autophagy-mediated therapy resistance, but these efforts have not yet led to the success of clinical applications. In a recent paper, we established a 37-gene autophagy signature to estimate the autophagy status of approximately 10,000 tumor samples across 33 cancer types from The Cancer Genome Atlas, and muti-omics characterization reveals that autophagy induction may also sensitize cancer cells to anti-cancer drugs. These findings provide a comprehensive resource of molecular alterations associated with autophagy and highlight the potential to utilize drug sensitivity induced by autophagy to overcome the resistance of cancer therapy.
引用
收藏
页码:2393 / 2394
页数:2
相关论文
共 50 条
  • [1] Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
    Oh, Taek-In
    Lee, Jun Ho
    Kim, Seongman
    Nam, Taek-Jin
    Kim, Young-Seon
    Kim, Byeong Mo
    Yim, Woo Jong
    Lim, Ji-Hong
    MOLECULES, 2018, 23 (01):
  • [2] Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy
    Cuomo, Francesca
    Altucci, Lucia
    Cobellis, Gilda
    CANCERS, 2019, 11 (10)
  • [3] Anti-cancer drugs
    Bergmann-Leitner, ES
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
  • [4] Anti-cancer drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048
  • [5] Anti-Cancer Drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
  • [6] CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation
    Chatterjee, Ranodeep
    Shukla, Aditya
    Chakrabarti, Kausiki
    Chatterji, Urmi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Anti-cancer drugs for thyroid cancer
    Tahara, Makoto
    ANNALS OF ONCOLOGY, 2017, 28 : 63 - 63
  • [8] Zerumbone Sensitizes the Anti-Cancer Efficacy of Cisplatin in Hepatocellular \nCarcinoma Cells
    Jegannathan, Srimathi Devi
    Arul, Santhosh
    Dayalan, Haripriya
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (16) : 2885 - 2895
  • [9] Teratogens as anti-cancer drugs
    Blagosklonny, MV
    CELL CYCLE, 2005, 4 (11) : 1518 - 1521
  • [10] Development of Anti-cancer Drugs
    Arrondeau, Jennifer
    Gan, Hui K.
    Razak, Albiruni R. A.
    Paoletti, Xavier
    Le Tourneau, Christophe
    DISCOVERY MEDICINE, 2010, 10 (53) : 355 - 362